- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-175/22: Judgment of the General Court of 15 March 2023 — Novartis v EUIPO — AstraZeneca (BREZTRI) (EU trade mark — Invalidity proceedings — EU word mark BREZTRI — Earlier EU word marks ONBREZ, BREZILIZER and BREEZHALER — No likelihood of confusion — Lack of enhanced distinctiveness of the earlier marks — Article 60(1)(a) and Article 8(1)(b) of Regulation (EU) 2017/1001 — Article 27(3)(b) of Regulation (EU) 2018/625)
ECLI:EU:UNKNOWN:62022TA0175
62022TA0175
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 164/39
(Case T-175/22) (1)
(EU trade mark - Invalidity proceedings - EU word mark BREZTRI - Earlier EU word marks ONBREZ, BREZILIZER and BREEZHALER - No likelihood of confusion - Lack of enhanced distinctiveness of the earlier marks - Article 60(1)(a) and Article 8(1)(b) of Regulation (EU) 2017/1001 - Article 27(3)(b) of Regulation (EU) 2018/625)
(2023/C 164/54)
Language of the case: English
Parties
Applicant: Novartis AG (Basle, Switzerland) (represented by: A. Nordemann-Schiffel, lawyer)
Defendant: European Union Intellectual Property Office (represented by: N. Lamsters and T. Frydendahl, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: AstraZeneca AB (Södertälje, Sweden) (represented by: C. Tenkhoff and T. Herzog, lawyers)
Re:
By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 21 January 2022 (Case R 737/2021-2).
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Novartis AG to pay the costs.
(1) OJ C 207, 23.5.2022.